FDA Blocks OxyContin Generics, Citing Abuse Risks

Law360, New York (April 16, 2013, 6:07 PM EDT) -- The Food and Drug Administration will not accept any applications to make a generic version of the popular painkiller OxyContin in its original, more easily abused form, which is due to come off patent this week, after the agency determined that the original OxyContin was pulled for safety reasons, it said Tuesday.

The decision will effectively prevent generics of OxyContin — one of the most popular drugs in the U.S., with $2.9 billion spent on it in 2011 — from coming onto the market for years....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.